微RNAs作为脑瘤的生物标志物
Wojciech Jelski1, Barbara Mroczko1,2
1Department of Biochemical Diagnostics, Medical University, Bialystok, Poland.
Cancer management and research
|October 9, 2024
概括
研究人员正在探索微RNAs (一种小RNA分子) 作为敏感的,低成本的生物标志物,用于早期脑瘤检测. 体液中的这些microRNA可以显著改善诊断和患者生存率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物标志物发现发现
背景情况:
- 大脑瘤是一个重大的瘤挑战,由于目前的诊断局限性,经常被诊断为晚.
- 早期发现脑瘤对于有效治疗和改善患者的治疗结果至关重要.
- 需要可访问和敏感的方法来识别癌症生物标志物.
研究的目的:
- 审查微RNAs作为脑瘤生物标志物的诊断潜力.
- 探索微RNA表达在脑脊液和血液中的作用,用于脑瘤诊断.
- 评估microRNAs在启用早期诊断和提高脑瘤患者的存活率方面的前景.
主要方法:
- 对调查脑瘤患者微RNA表达的研究进行文献综述.
- 在脑脊髓液和血液样本中分析微RNA变化.
- 评价microRNAs作为潜在的诊断生物标志物.
主要成果:
- 身体液体中的微RNA表达水平与癌症的存在相关.
- 在脑脊髓液和脑瘤患者的血液中观察到改变的microRNA概况.
- 微RNAs显示为早期脑瘤检测的敏感指标的承诺.
结论:
- 微RNA正在成为早期诊断脑瘤的有价值的生物标志物.
- 利用microRNA可以促进及时的治疗干预,从而改善患者的预后.
- 进一步研究基于microRNA的诊断方法对神经瘤学有很大的潜力.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K